Delays of Event Adjudication in the TRITON Trial

Publisher： Karger

E-ISSN： 1421-9751|115|3|217-220

ISSN： 0008-6312

Source： Cardiology, Vol.115, Iss.3, 2010-03, pp. : 217-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interpreting the TRITON Results in Light of the Event Adjudication Process

By  

Cardiology, Vol. 115, Iss. 2, 2009-11 ,pp. : 89-90

Karger

Access to resources Recommend Favorite

Sentinel Event Alert: Delays in treatment

By  

JCAH Perspectives, Vol. 22, Iss. 8, 2002-08 ,pp. : 10-11

Joint Commission Resources

Access to resources Recommend Favorite

Bleeding Risks with Prasugrel in the TRITON Trial: Good News ... Bad News

By  

Cardiology, Vol. 111, Iss. 4, 2008-04 ,pp. : 265-267

Karger

Access to resources Recommend Favorite

The FDA Prasugrel Review: Adjudication of Myocardial Infarction Controversy

By  

Cardiology, Vol. 114, Iss. 2, 2009-06 ,pp. : 126-129

Karger

Access to resources Recommend Favorite

ICARUSS, the Integrated Care for the Reduction of Secondary Stroke trial: rationale and design of a randomized controlled trial of a multimodal intervention to prevent recurrent stroke in patients with a recent cerebrovascular event, ACTRN = 12611000264987

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 5, 2015-07 ,pp. : 773-777

John Wiley & Sons Inc

Access to resources Recommend Favorite